Partner Stuart Fross was quoted in a Board IQ article, “With Zero-Fee Funds, What’s a Board to Do at 15(c) Time?,” covering what Fidelity’s almost 20 no-fee funds mean for boards during their 15(c) contract renewal process.
Fross shares insights on all effects of the changes, including that, because of these changes, the need to have data on market behavior, investments and funds is now not vital during the 15(c) process. He also said that it’s now unnecessary to do the Gartenberg factors because there is no profitability in it. In addition, though, he points out other outcomes that will come of Fidelity’s new structure, saying that the no-fee funds make it a possibility to negotiate a fund’s investment management fee.
Fross shares insights on all effects of the changes, including that, because of these changes, the need to have data on market behavior, investments and funds is now not vital during the 15(c) process. He also said that it’s now unnecessary to do the Gartenberg factors because there is no profitability in it. In addition, though, he points out other outcomes that will come of Fidelity’s new structure, saying that the no-fee funds make it a possibility to negotiate a fund’s investment management fee.
People
Related News
14 February 2025
In the News
Brian Wheeler Joins Podcast to Discuss Legal Journey
Foley & Lardner LLP partner Brian Wheeler joined the Hsu Untied podcast to discuss his legal career.
14 February 2025
In the News
Pavan Agarwal Featured in Leadership Q&A – 'Reflecting our firm’s core values drives me to do my best'
Foley & Lardner LLP partner Pavan Agarwal is featured by Law.com for his career journey, legal practice, and leadership in the article, “How I Made Practice Group Chair: ‘Keep Listening and Keep Learning,’ Says Pavan Agarwal of Foley & Lardner.”
14 February 2025
In the News
Judith Waltz on Trump Administration Deregulation Order, Impact on CMS
Foley & Lardner LLP partner Judith Waltz commented on the Trump administration's executive order requiring federal agencies cut ten regulations for each newly created one in the Modern Healthcare article, "CMS may evade Trump's sweeping deregulation order."